ArticleMaterials (Basel, Switzerland)2020
Application of Boroisoquinoline Fluorophores as Chemodosimeters for Fluoride Ion and Pd (0).
Article in Materials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Synthesis and characterization of new fluorescent boro-β-carboline dyes.RSC advances · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The development of novel chemodosimeters is currently a prosperous field in organic chemistry. Recently, a new family of fluorophores, the boroisoquinolines, were introduced with satisfying photophysical properties. As a continuation of this research, the application of boroisoquinolines is presented as chemodosimeters for fluoride anion and Pd (0). The new tools showed good selectivity for the detection of the analytes. Moreover, the mechanism of action was investigated experimentally.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.